Other,Other,Other,Other,Other

4 trials

Sponsors

none, Faculty of Medicine, Chulalongkorn University, Navamindradhiraj University Research Fund, Ophthalmology Department, Faculty of medicine Ramathibodi hospital , Mahidol University

Conditions

Do the Repackaged Bevacizumab for Intravitreal Administration still have the same Sterility Stability and Efficacy at Day 0 Day 14 Day 30 after storage Do the Repackaged Aflibercept for Intravitreal Administration still have the same Sterility Stability and Efficacy at Day 0 Day 14 Day 30 after storage Do the Repackaged Ranibizumab for Intravitreal Administration still have the same Sterility Stability and Efficacy at Day 0 Day 14 Day 30 after storage Do the Repackaged Brolucizumab for IntHIV Elite controller Viremic controller HIV Elite controller Viremic controllerThe distribution of Oxford phase 3 unicompartmental knee arthroplasty prosthetic size, and the influencing factors for selecting the femoral component size in Thai patients with medial osteoarthritic knees Unicompartmental knee arthroplasty Distribution of prosthesis Femoral component sizeTo identify correlation between the GALAD score and tumor feature, HCC staging and patient survival. Hepatocellular carcinoma , GALAD , tumor feature , Survival, HCC staging

Unknown Phase

Oxford phase 3 unicompartmental knee arthroplasty in Thailand: Distribution of prosthetic size and height based on gender distribution of femoral component size

Active, not recruitingTCTR20210922002

noneThe distribution of Oxford phase 3 unicompartmental knee arthroplasty prosthetic size, and the influencing factors for selecting the femoral component size in Thai patients with medial osteoarthritic knees Unicompartmental knee arthroplasty Distribution of prosthesis Femoral component size

Start: 2021-09-27Target: 700Updated: 2026-08-03

The Prevalence of HIV Elite Controllers, Viremic Controllers, False Elite Controllers, and False Viremic Controllers in Thai Blood Donors

RecruitingTCTR20210927003

Faculty of Medicine, Chulalongkorn UniversityHIV Elite controller Viremic controller HIV Elite controller Viremic controller

Start: 2021-07-23Target: 93Updated: 2026-08-03

A prospective investigation of the association between GALAD score and the features and survival of hepatocellular carcinoma.

Active, not recruitingTCTR20230312003

Navamindradhiraj University Research FundTo identify correlation between the GALAD score and tumor feature, HCC staging and patient survival. Hepatocellular carcinoma , GALAD , tumor feature , Survival, HCC staging

Start: 2021-09-10Target: 115Updated: 2026-08-03

Evaluation of Sterility, Stability, and Efficacy of Repackaged Bevacizumab, Aflibercept, Ranibizumab, Brolucizumab, and Faricimab for Intravitreal Administration: An Experimental Study

Active, not recruitingTCTR20240924004

Ophthalmology Department, Faculty of medicine Ramathibodi hospital , Mahidol UniversityDo the Repackaged Bevacizumab for Intravitreal Administration still have the same Sterility Stability and Efficacy at Day 0 Day 14 Day 30 after storage Do the Repackaged Aflibercept for Intravitreal Administration still have the same Sterility Stability and Efficacy at Day 0 Day 14 Day 30 after storage Do the Repackaged Ranibizumab for Intravitreal Administration still have the same Sterility Stability and Efficacy at Day 0 Day 14 Day 30 after storage Do the Repackaged Brolucizumab for Int

Start: 2024-04-10Target: 5Updated: 2026-08-03